FDA Import Refusal 799-7334947-3/11/1 — NARBAVI
The FDA refused shipment 799-7334947-3/11/1 from NARBAVI (India) on Jun 16, 2020. The refused product falls under Drugs and Biologics — IRBESARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Jun 16, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62OCA37 IRBESARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75